You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Multifunction High Throughput System for Neurophysiology of Behavior

    SBC: BIOGRAPHICS, INC.            Topic: 500

    DESCRIPTION provided by applicant The goal of this project is to create a system to conduct research with the assistance of a andapos High Throughput Multifunction System for Neurophysiology of Behaviorandapos This Phase II application to the Omnibus Solicitation is based on the Phase I for PA that was funded by NIAAA R AA The advanced system will provide capabilities for m ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  2. Peptide-coated skin substitutes for the treatment of burn injuries and wounds

    SBC: AFFINERGY, LLC            Topic: 300

    DESCRIPTION provided by applicant Burn injuries and chronic wounds present a significant burden to patients and the US healthcare system Each year in the US there are burns that require medical treatment and burn patients that require hospitalization The mortality rate associated with severe burns can be as high as with of patient deaths arising from infection In add ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  3. RFID Based Tracking System for Ultra-Low Temperature Sample Repositories

    SBC: BIOTILLION LLC            Topic: OD

    DESCRIPTION (provided by applicant): The specific aim of this Phase IIb (Phase II competitive renewal) SBIR proposal is to advance the prototype systems we developed under our Phase II grant into commercial production. Our product will be used to automatically track samples in laboratory and biobank freezers. Most of these samples are stored in vials. Between 200 and 500 million such vials are ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  4. RFID Based Tracking System for Ultra-Low Temperature Sample Repositories

    SBC: BIOTILLION LLC            Topic: 100

    DESCRIPTION provided by applicant The specific aim of this Phase IIb Phase II competitive renewal SBIR proposal is to advance the prototype systems we developed under our Phase II grant into commercial production Our product will be used to automatically track samples in laboratory and biobank freezers Most of these samples are stored in vials Between and million such vials are ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  5. Targeting B-cell lymphoma with Leukothera-phase II

    SBC: Actinobac Biomed, Inc.            Topic: NCI

    DESCRIPTION provided by applicant B cell lymphoma is cancer of B lymphocytes and accounts for more than deaths in the U S each year While many patients respond to currently available therapy there is a high rate of cancer relapse and inability for the patients o tolerate chemotherapy Thus there is a significant need to make available to these patients newer therapies that are more e ...

    STTR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  6. Gene Expression Signatures to Predict Treatment Response in Systemic Sclerosis

    SBC: CELDARA MEDICAL, LLC            Topic: NIAMS

    DESCRIPTION provided by applicant Today systemic sclerosis SSc clinical trials generally include all subsets some may benefit others do not confounding measures of efficacy Because each expression subset has a different underlying deregulated molecular pathway no single drug is expected to benefit all patients i e rational patient selection is required to facilitate drug development F ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  7. See It Be It: Interactive Technology to Increase School Engagement and Prevent Dropout

    SBC: 3-C Institute for Social Development, Inc.            Topic: NIMHD

    DESCRIPTION provided by applicant Dropping out of school costs the nation up to $ billion annually in lost wages unemployment incarceration costs welfare dependence and health care costs Moreover poorer individual health and well being result from dropping out Despite recent reductions in the total number of dropouts minority students remain twice as likely to drop out as White stud ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  8. Validation of a Negative Regulator as a Novel Therapy for Autoimmune Disease

    SBC: Immunext, Inc.            Topic: NIAID

    DESCRIPTION provided by applicant Systemic lupus erythematosus SLE is a devastating autoimmune disease that most commonly affects women in their child bearing years SLE attacks multiple organ systems but renal and neurologic involvement are the usual harbingers of poor outcome Despite effective albeit toxic immunosuppressive therapy only of patients with these serious manifestations ...

    STTR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  9. Subcutaneous Acute Ischemia Monitor

    SBC: ANGEL MEDICAL SYSTEMS, INC.            Topic: NHLBI

    DESCRIPTION provided by applicant Abstract This project consists of the continued development of a unique implantable ischemia monitor that uses subcutaneous sensors in the patientandapos s torso to detect the onset of acute myocardial infarction AMI Upon detecting a heart attack the monitor generates an alarm which enables the patient to promptly seek medical treatment In the United Stat ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  10. Novel therapeutics for fatty liver disease and type-II diabetes

    SBC: SOUTHEAST TECHINVENTURES INC            Topic: 200

    DESCRIPTION provided by applicant Western lifestyle and diet have spurred the growth of numerous obesity related disorders in the US including metabolic syndrome and type diabetes to epidemic proportions However less well known is the rising epidemic of non alcoholic fatty liver disease NAFLD NAFLD ranges from mild hepatosteatosis to severe fibrosis or cirrhosis and is initially charac ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government